| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |